24
Dec

Here’s a perennial favorite among the top trends in the industry. About six years ago, most of Big Pharma got serious about one of its biggest problems: they were really, really bad at drug development.

…read more

Source: Approvals aren’t enough; Big Pharma R&D restructuring will continue

    

0 No comments